Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells

Junjie Liu1,2,3, Chunyu Zhu1, Lihua Xu1

  • 1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Nano Letters
|October 16, 2020
PubMed

Insights

This study introduces a novel tumor-targeting calcium ion nanogenerator (TCaNG) to overcome multidrug resistance (MDR) in cancer. TCaNG induces calcium ion bursting, effectively reversing chemotherapy resistance and inhibiting tumor growth.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Multidrug resistance (MDR) is a major obstacle in clinical chemotherapy, leading to treatment failure.
  • Tumor cells often develop resistance through mechanisms like P-glycoprotein (P-gp) overexpression.
  • Novel strategies are needed to overcome MDR and improve chemotherapeutic efficacy.

Purpose of the Study:

  • To develop a tumor-targeting "calcium ion nanogenerator" (TCaNG) capable of reversing MDR.
  • To investigate the mechanisms by which TCaNG overcomes drug resistance.
  • To evaluate the efficacy and safety of TCaNG in preclinical models.

Main Methods:

  • Design and synthesis of a tumor-targeting calcium ion nanogenerator (TCaNG).
  • Induction of intracellular calcium ion (Ca2+) bursting in acidic tumor lysosomes.
  • Assessment of TCaNG's impact on mitochondrial respiration, ATP production, and P-gp expression.
  • Evaluation of TCaNG's ability to reverse doxorubicin (DOX) resistance in MCF-7/ADR cells and inhibit drug-resistant tumor proliferation.

Main Results:

  • TCaNG successfully induced Ca2+ bursting in acidic tumor lysosomes.
  • Ca2+ accumulation in mitochondria suppressed respiration, reduced tumor hypoxia, and downregulated HIF-1α expression, inhibiting P-gp biosynthesis.
  • ATP production was blocked by Ca2+-induced respiratory depression, leading to P-gp incompetence.
  • TCaNG decreased the IC50 of DOX to MCF-7/ADR cells by approximately 30-fold and reduced tumor proliferation by approximately 13-fold with minimal side effects.

Conclusions:

  • The TCaNG is a simple, versatile, and effective tool for reversing multidrug resistance in tumors.
  • The "Ca2+ bursting" strategy offers a promising approach for enhancing chemotherapy efficacy.
  • TCaNG demonstrates potential for clinical translation in cancer treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.3K